Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)

Exclusion criteria

• ✕. After inquiry, it is found that there is a history of rabies vaccination or the use of passive immunization preparations for rabies virus.
• ✕. There was a history of injury from rabies virus-susceptible animals (such as cats and dogs) before the first dose of vaccination;
• ✕. The axillary body temperature of the participants on the day of enrollment was ≥37.3℃\*;
• ✕. Women who have a positive urine pregnancy trial before vaccination (on the day of vaccination), or who, after assessment, cannot rule out the possibility of pregnancy or are breastfeeding;
• ✕. Hypertension that cannot be controlled by medication, such as systolic blood pressure ≥160mmHg and/or diastolic blood pressure ≥100mmHg for participants aged 18 years and above before enrollment;
• ✕. Allergy to any component of the vaccine used in the trial, such as human albumin, sucrose, or maltose;
• ✕. Those with a history of severe allergies in the past, such as anaphylactic shock, allergic laryngeal edema, allergic purpura, local allergic necrosis reaction (Arthus reaction), severe urticaria, allergic bronchitis, acquired angioedema, etc.
• ✕. Has been diagnosed with congenital or acquired immune system diseases, such as the Human Immunodeficiency Virus. HIV infection, lymphoma, leukemia, systemic lupus erythematosus, rheumatoid arthritis, juvenile rheumatoid arthritis, inflammatory bowel disease or other immune diseases that the researcher deems likely to affect the trial assessment;